Article
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model
Oncotarget
(2015)
Disciplines
Publication Date
December 15, 2015
DOI
10.18632/oncotarget.6442
Citation Information
Mark Duquette, Peter M. Sadow, Amjad Husain, Jennifer N. Sims, et al.. "Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model" Oncotarget Vol. 6 Iss. 40 (2015) p. 42445 - 42467 Available at: http://works.bepress.com/zeus-antonello/5/